These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 28821620)

  • 1. Arjunolic acid, a peroxisome proliferator-activated receptor α agonist, regresses cardiac fibrosis by inhibiting non-canonical TGF-β signaling.
    Bansal T; Chatterjee E; Singh J; Ray A; Kundu B; Thankamani V; Sengupta S; Sarkar S
    J Biol Chem; 2017 Oct; 292(40):16440-16462. PubMed ID: 28821620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
    Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
    Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats.
    Matsumoto-Ida M; Takimoto Y; Aoyama T; Akao M; Takeda T; Kita T
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H709-15. PubMed ID: 16183734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
    Zhang ZZ; Shang QH; Jin HY; Song B; Oudit GY; Lu L; Zhou T; Xu YL; Gao PJ; Zhu DL; Penninger JM; Zhong JC
    J Transl Med; 2013 Sep; 11():229. PubMed ID: 24067190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBXW5 acts as a negative regulator of pathological cardiac hypertrophy by decreasing the TAK1 signaling to pro-hypertrophic members of the MAPK signaling pathway.
    Hui X; Hu F; Liu J; Li C; Yang Y; Shu S; Liu P; Wang F; Li S
    J Mol Cell Cardiol; 2021 Feb; 151():31-43. PubMed ID: 32971071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decorin gene delivery inhibits cardiac fibrosis in spontaneously hypertensive rats by modulation of transforming growth factor-beta/Smad and p38 mitogen-activated protein kinase signaling pathways.
    Yan W; Wang P; Zhao CX; Tang J; Xiao X; Wang DW
    Hum Gene Ther; 2009 Oct; 20(10):1190-200. PubMed ID: 19697998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-β signalling.
    Zhang H; Wu J; Dong H; Khan SA; Chu ML; Tsuda T
    Clin Sci (Lond); 2014 Feb; 126(4):275-88. PubMed ID: 23841699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olmesartan ameliorates pressure overload-induced cardiac remodeling through inhibition of TAK1/p38 signaling in mice.
    Wu L; Mei L; Chong L; Huang Y; Li Y; Chu M; Yang X
    Life Sci; 2016 Jan; 145():121-6. PubMed ID: 26706286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A direct interaction between TGFbeta activated kinase 1 and the TGFbeta type II receptor: implications for TGFbeta signalling and cardiac hypertrophy.
    Watkins SJ; Jonker L; Arthur HM
    Cardiovasc Res; 2006 Feb; 69(2):432-9. PubMed ID: 16360132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction.
    Cheng M; Wu G; Song Y; Wang L; Tu L; Zhang L; Zhang C
    Cell Physiol Biochem; 2016; 38(5):1928-38. PubMed ID: 27160852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway.
    Ma SQ; Guo Z; Liu FY; Hasan SG; Yang D; Tang N; An P; Wang MY; Wu HM; Yang Z; Fan D; Tang QZ
    Acta Pharmacol Sin; 2021 Oct; 42(10):1575-1586. PubMed ID: 33462378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response.
    Barger PM; Browning AC; Garner AN; Kelly DP
    J Biol Chem; 2001 Nov; 276(48):44495-501. PubMed ID: 11577087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gramine protects against pressure overload-induced pathological cardiac hypertrophy through Runx1-TGFBR1 signaling.
    Xu L; Su Y; Yang X; Bai X; Wang Y; Zhuo C; Meng Z
    Phytomedicine; 2023 Jun; 114():154779. PubMed ID: 37023527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotized PPARα Overexpression Targeted to Hypertrophied Myocardium Improves Cardiac Function by Attenuating the p53-GSK3β-Mediated Mitochondrial Death Pathway.
    Rana S; Datta R; Chaudhuri RD; Chatterjee E; Chawla-Sarkar M; Sarkar S
    Antioxid Redox Signal; 2019 Feb; 30(5):713-732. PubMed ID: 29631413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-beta1-induced MKK3-p38 MAPK activation and stimulation of type I collagen.
    Kim SI; Kwak JH; Zachariah M; He Y; Wang L; Choi ME
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1471-8. PubMed ID: 17299140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress.
    Sriramula S; Francis J
    PLoS One; 2015; 10(9):e0138372. PubMed ID: 26378790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAK1 mediates apoptosis via p38 involve in ischemia-induced renal fibrosis.
    Zhou J; Zhong J; Huang Z; Liao M; Lin S; Chen J; Chen H
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1016-1025. PubMed ID: 29661023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart.
    Mir SA; Chatterjee A; Mitra A; Pathak K; Mahata SK; Sarkar S
    J Biol Chem; 2012 Jan; 287(4):2666-77. PubMed ID: 22157761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-fibrotic role of AcSDKP through inhibition of P38MAPK pathway activity mediated transforming growth beta receptors in rat with silicosis].
    Wei Z; Sun Y; Cheng H; Ma W; Xu H; Li Q; Zhang L; Wang R; Yang F
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 May; 32(5):340-7. PubMed ID: 25169087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-beta expression in adult ventricular cardiomyocytes.
    Wenzel S; Taimor G; Piper HM; Schlüter KD
    FASEB J; 2001 Oct; 15(12):2291-3. PubMed ID: 11511516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.